Lukas A. Basedow, PhD
banner
labasedow.bsky.social
Lukas A. Basedow, PhD
@labasedow.bsky.social
Postdoc & Clinical Psychologist @unimarburg.bsky.social‬ & @SFB-TRR-289.bsky.social
Coordinator of the DG Sucht - ECR network.
Interested in placebo effects, drugs & clinical psychology. All views my own.
Well, this preprint would agree with you: osf.io/preprints/ps...
"Contrary to prior hypothesis, PAT was no more effective than open-label tAD treatment (estimated difference: 0.3 favoring open-label tAD; 95% confidence interval: [-1.39, 1.98]; p=0.730)."
OSF
osf.io
June 26, 2025 at 10:41 AM
There is definitely an argument to be made that we basically induced an ASC through a setting fostering meditative processes which are reflected in the 5D-ASC scales. We're still collecting data though, so a comprehensive answer will have to wait a while :)
June 20, 2025 at 8:42 AM
Reposted by Lukas A. Basedow, PhD
Huge congratulations to our two CRC members @labasedow.bsky.social and Marcel Wilhelm from @unimarburg.bsky.social for winning two out of four science slam prizes! 🥳🤯

Of course we also congratulate @ldruart.bsky.social and Pavel Goldstein for the other two awards - all super deserved! 🤩
June 18, 2025 at 12:39 PM